Vascular Contributions to Cognitive Impairment and Dementia
Abstract
Vascular contributions to cognitive impairment and dementia are important. Understanding of VCI has evolved substantially in recent years, based on preclinical, neuropathologic, neuroimaging, physiological, and epidemiological studies. Transdisciplinary, translational, and transactional approaches are recommended to further our understanding of this entity and to better characterize its neuropsychological profile. There is a need for prospective, quantitative, clinical-pathological-neuroimaging studies to improve knowledge of the pathological basis of neuroimaging change and the complex interplay between vascular and Alzheimer disease pathologies in the evolution of clinical VCI and Alzheimer disease. Long-term vascular risk marker interventional studies beginning as early as midlife may be required to prevent or postpone the onset of VCI and Alzheimer disease. Studies of intensive reduction of vascular risk factors in high-risk groups are another important avenue of research.
MeSH terms
Funding
- American Heart Association
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Massachusetts General Hospital
- University of Southern California
- University of Minnesota
- University of Pittsburgh
- Minneapolis Heart Institute
- Rush University
- Daiichi-Sankyo
- University of Toronto
- Eisai
- Servier
- H. Lundbeck A/S
- National Institutes of Health
- University of Illinois at Urbana-Champaign
- Weill Cornell Medical College
- University of California, Davis
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
How this paper connects to the literature. Drag to explore, click any node to open that paper.
